Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
| Image |  |
|---|---|
| Description | scientific article published on 01 November 2019 |
| Author/s |
author: Barbara Burtness Danny Rischin |
| Publication date | November 1, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |